| Patent application number | Description | Published |
|---|
| 20080289763 | STRIPING APPARATUS AND STRIPING METHOD - The present invention relates to a striping apparatus and a striping method. The apparatus for stripping a film from a product comprising a transfer device for transferring the product; a film stripping device disposed above a stripping operation area of the transfer device for stripping the film from the product; and a plurality of guiding devices disposed on both sides of the transfer device in the stripping operation area for guiding the transfer direction of the product. | 11-27-2008 |
| 20090269843 | Hemopexin fusion proteins - Fusion proteins comprising a first protein fused to hemopexin are provided, said fusion proteins exhibit an increased circulation time. | 10-29-2009 |
| 20090306352 | Basic Protein Purification Tags from Thermophilic Bacteria - The invention is related to a method for purification of recombinant proteins using highly basic proteins from thermophilic bacteria as purification tags for use in a cation-exchange chromatography purification step. The basic proteins may be ribosomal proteins. The recombinant proteins are expressed in eukaryotic or prokaryotic host cells. The purification tag will typically have a pl above about 9 and comprise from about 15 to about 250 amino acid residues. | 12-10-2009 |
| 20100087371 | Transglutaminase Variants with Improved Specificity - Variants of transglutaminase from | 04-08-2010 |
| 20100099610 | Transglutaminase Variants with Improved Specificity - Variants of transglutaminase from | 04-22-2010 |
| 20100179116 | Arene Connected Polyamine Macrocyclic Derivatives, Preparation Methods and Pharmaceutical Uses Thereof - The present invention relates to arene connected polyamine macrocyclic derivatives represented by general formula I, pharmaceutically acceptable salts or hydrates thereof which have anti-HIV activities, in which the definitions of substituents are as defined in the description; to preparation methods of the compounds of formula I; to pharmaceutical compositions containing the compounds of formula I or their pharmaceutically acceptable salts or hydrates; to the use of the compounds of formula I or their pharmaceutically acceptable salts or hydrates for the preparation of a medicament for the treatment and prevention of HIV-associated diseases. | 07-15-2010 |
| 20110052606 | Humanized Anti-Human NKG2A Monoclonal Antibody - The present invention relates to agents that are non-competitive antagonists of the CD94/NKG2A receptor such as certain anti-NKG2A antibodies, in particular humanized versions of murine anti-NKG2A antibody Z199, as well as methods of producing and using such agents and antibodies. | 03-03-2011 |
| 20110236929 | E. COLI BL21 STRAIN LACKING A FUNCTIONAL GROUP II CAPSULAR GENE CLUSTER - The present invention relates to a novel non-pathogenic | 09-29-2011 |
